Clinical Trial Detail

NCT ID NCT03681483
Title RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

non-small cell lung carcinoma

Therapies

RO5126766

Age Groups: adult senior

Additional content available in CKB BOOST